Polls | Vascular Disease Management

Cardiologists are set to become significant players in neurointerventional care. - 2 votes - open
Drug-eluting balloons will have a major role in lower-extremity revascularization in the future. - 14 votes - open
Drug-eluting stents will become the standard and predominant therapy for the superficial femoral artery in the future. - 16 votes - open
Incidence of this is declining: - 12 votes - open
Endarterectomy will reign supreme over carotid stenting far into the future. - 35 votes - open
Drug-eluting balloons are exciting but are as yet largely unproven devices. - 18 votes - open
What difference will the FDA approval of 14F EVAR make? - 40 votes - open
Interventional radiologists can't compete with a vascular/endovascular practice because they don't provide patient care. - 25 votes - open
Recently approved fenestrated aortic stent-grafts are game changers as more patients can now be offered endovascular treatment - 21 votes - open
Areas of present and future growth in peripheral intervention would include: - 12 votes - open
What do you think about using covered stents for the treatment of infrainguinal arterial occlusions? - 22 votes - open
Venous intervention for treatment of CCSVI (in multiple sclerosis) should be regarded as experimental and unproven: - 37 votes - open
Interventional cardiologists will play a role in intracranial interventions as the field continues to grow: - 28 votes - open
The current focus to decrease the profile size of aortic stent-grafts: - 17 votes - open
Venous stenting for the treatment of chronic cerebrovascular venous insufficiency in MS patients: - 20 votes - open

REVIEW OUR OTHER Cardiology BRANDS

Our other resources for healthcare professionals.

HMP Communications © 2013 HMP Communications